id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-E-0218-0004,FDA,FDA-2003-E-0218,Determination of Regulatory Review Period for Purposes of Patent Extension; INSPRA,Notice,General Notice,2006-06-19T04:00:00Z,2006,6,2006-06-16T04:00:00Z,,2025-10-27T16:17:52Z,71 FR 34944,0,0,090000648048cb68
FDA-2003-E-0218-0003,FDA,FDA-2003-E-0218,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-05-24T04:00:00Z,2006,5,,,2025-10-27T16:07:33Z,,0,0,090000648048cb67
FDA-2003-E-0218-0002,FDA,FDA-2003-E-0218,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-05-23T04:00:00Z,2006,5,,,2025-10-27T16:02:59Z,,0,0,090000648048cb64